Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, April 10, 2012

Stem cells for stroke?

A phase II trial.
http://www.wftv.com/news/news/health-med-fit-science/stem-cells-stroke/nMWRH/
BREAKTHROUGH STEM CELL STUDY: Stem cells are the body's raw materials — cells from which all other cells with specialized functions are generated. Researchers hope to train stem cells into becoming specific cells so that those specialized cells can be used to regenerate and repair diseased or damaged tissues in people. Both polypeptide growth factors and stem cell populations from bone marrow and umbilical cord blood hold promise as treatments to enhance neurologic recovery after a stroke. The ALD-401 trial is a phase 2 study with a phase 1 safety cohort testing ALD-401 stem cells derived from autologous bone marrow delivered via intracarotid infusion in subjects with ischemic stroke. All study assessments are blinded. This trial is the first trial in the United States and in the world to study the infusion of stem cells into the human brain. SOURCE: (www.labrainandspine.com); (www.mayoclinic.com); (www.ncbi.nlm.nih.gov/pubmedhealth)
Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)